Divi's Laboratories · NSE: DIVISLAB · BSE: 532488
Q1 FY23 results · Apr–Jun 2022
Divi's Laboratories reported revenue from operations of ₹2,254.52 crore (up 15.0% from Q1 FY22) and net profit of ₹702.01 crore (up 26.0% from Q1 FY22) for Q1 FY23 (Apr–Jun 2022), on a consolidated basis.
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,254.52 | 1,960.64 | +15.0% | 2,518.44 | −10.5% |
| Other income | 88.39 | 35.97 | +145.7% | 52.39 | +68.7% |
| Total income | 2,342.91 | 1,996.61 | +17.3% | 2,570.83 | −8.9% |
| Profit before tax | 851.30 | 814.48 | +4.5% | 1,075.74 | −20.9% |
| Net profit for the period | 702.01 | 557.11 | +26.0% | 894.64 | −21.5% |
| EPS, basic (₹) | 26.44 | 20.99 | +26.0% | 33.70 | −21.5% |
| Net margin (%) | 31.1 | 28.4 | 35.5 |
| Item | Q1 FY23 | Q1 FY22 | YoY | Q4 FY22 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 2,203.92 | 1,950.16 | +13.0% | 2,495.03 | −11.7% |
| Other income | 89.99 | 35.55 | +153.1% | 50.51 | +78.2% |
| Total income | 2,293.91 | 1,985.71 | +15.5% | 2,545.54 | −9.9% |
| Profit before tax | 844.05 | 813.77 | +3.7% | 1,065.69 | −20.8% |
| Net profit for the period | 691.61 | 551.97 | +25.3% | 882.96 | −21.7% |
| EPS, basic (₹) | 26.05 | 20.79 | +25.3% | 33.26 | −21.7% |
| Net margin (%) | 31.4 | 28.3 | 35.4 |
Consolidated
- Filed with BSE
- 13 Aug 2022, 12:15 IST
- Board meeting
- 12 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 13 Aug 2022, 12:15 IST
- Board meeting
- 12 Aug 2022
- Period
- 01 Apr 2022 to 30 Jun 2022
- Review status
- Unaudited
- Source
- XBRL filing on BSE